4 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow Smokers: new trials by email Literature Review of Smokers trials Research Report on Smokers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nicotine Patch Safety Study V0116 transdermal patch, Nicotine transdermal patch - Smokers | Phase 2 | Completed | Pierre Fabre Medicament | 160 | 2012-08-01 | 2012-12-11 |
| Study to Evaluate the Efficacy, Safety, Tolerability and Immunogenicity of 100µg NIC002 Vaccine in Cigarette Smokers Who Are Motivated to Quit Smoking. NIC002, Placebo - Smokers | Phase 2 | Completed | Novartis | 200 | 2008-08-01 | 2017-03-21 |
| 4 mg Nicotine Polacrilex Gum and Swedish Portion Snus Nicotine - Healthy Subjects, Smokers | Phase 1 / Phase 2 | Completed | Contract Research Organization el AB | 15 | 2006-03-01 | 2010-08-16 |
| Efficacy and Safety of Nicotine-Qbeta Vaccine in Smokers CYT002-NicQb - Smokers | Phase 2 | Completed | Cytos Biotechnology AG | 341 | 2003-12-01 | 2010-11-15 |
Smoking Cessation (2) · Tobacco Use Disorder (1)
Behavior (2) · Health Behavior (2) · Chemically-Induced Disorders (1) · Mental Disorders (1) · Substance-Related Disorders (1)
Chewing Gum (1) · Nicotine (1) · Nicotine Chewing Gum (1) · Tobacco Use Cessation Devices (1) · nicotine Qbeta vaccine (1)
Contract Research Organization el AB (1) · Cytos Biotechnology AG (1) · Novartis (1) · Pierre Fabre Medicament (1)
France (1) · Germany (1) · Sweden (1) · Switzerland (1)
Erik Lunell, MD, PhD (1) · Felix Jungi, MD (1) · Jacques Cornuz, Prof. (1) · Karl Klingler, MD (1) · Thomas Cerny, Prof. (1)